Foreign governments are reportedly skirting international sanctions through the use of cryptocurrency. Axios' reporter Shannon Vavra explains the dangers of this digital currency, and challenges facing regulators.
"The fact that sanctions, regimes, and regulations right now aren't keeping up with the innovation in cryptocurrency is something that leaders around the world are bound to be watching right now," says Vavra.
Cryptocurrencies are able to mask illicit activities because they function across borders, are pseudo-anonymous, and can provide plausible deniability. Challenges facing regulators include the pace of cryptocurrency innovation, and risk in over-regulating and hampering innovation.
Best Buy lowered its sales outlook for the rest of the year despite a positive quarterly earnings report.
X Corp, formerly known as Twitter, is facing over 2,200 arbitration cases.
Google Flight added a new feature that tracks flight prices.
Businesses posted far fewer open jobs in July and the number of Americans quitting their jobs fell sharply for the second straight month, clear signs that the labor market is cooling in a way that could reduce inflation.
American Airlines said it was fined $4.1 million for keeping passengers on planes during long on-ground delays.
3M said it will pay $6 billion to settle lawsuits claiming that it sold defective earplugs to the U.S. military.
Meta said it disrupted a campaign of disinformation linked to Chinese law enforcement.
Buying your first home can be challenging with rising interest rates and other costs. Cheddar News spoke with Amira Elgoneimy, a premiere agent with Redfin who caters to the New Brunswick, NJ area, and Daryl Fairweather, chief economist with Redfin, about the process involved in purchasing a residence in a competitive market.
Experts from Redfin real estate brokerage explain the challenges buyers are experiencing as they try to buy their first homes.
The Biden administration is targeting the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications for Medicare's first-ever drug price negotiations as it seeks to lower medical costs for Americans.
